TNXP
Closed
Tonix Pharmaceuticals Holding Corp
0.1425
0.0000 (0.00%)
Last Update: 06 Sep 2024 23:27:00
Yesterday: 0.1425
Day's Range: 0.1313 - 0.16
Send
sign up or login to leave a comment!
When Written:
0.5802
Tonix Pharmaceuticals Holding Corp is a clinical-stage biopharmaceutical company that develops and commercializes drugs for psychiatric and neurological disorders. The company's lead product candidate is TNX-102 SL, a sublingual tablet formulation of cyclobenzaprine for the treatment of fibromyalgia and post-traumatic stress disorder (PTSD). Tonix is also developing TNX-601, a small molecule antagonist of the corticotropin-releasing hormone type 1 receptor, for the treatment of PTSD and alcohol use disorder. The company was founded in 2007 and is headquartered in New York City.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!